ESPITAZ 2.25

Composition: Piperacillin 2 gm + Tazobactam 250 mg
Packing: 1 vial
Dosage Form: Parenteral-Dry Injection
DPCO

Description

Composition- Piperacillin 2 gm + Tazobactam 250 mg

Mode of Action- Piperacillin inhibits bacterial cell wall synthesis while Tazobactam inhibits β-lactamase enzymes, extending coverage against resistant organisms.

USPs- Broad-spectrum injectable antibiotic; effective against β-lactamase producing bacteria; useful in moderate to severe infections.

Prescribing Specialties- Physician, Surgeon, Critical Care